logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Dapoxe-tine Hydrochloride CAS 129938-20-1

Dapoxe-tine Hydrochloride CAS 129938-20-1

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 129938-20-1

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Bag,Drum

Delivery Time: 7-15 days

Payment Terms: L/C, D/A, T/T, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
129938-20-1
Appearance::
White To Off-white Crystalline Solid
Molecular Formula::
C21H24ClNO
Molecular Weight::
341.87400
EINECS NO::
640-411-8
MDL NO::
MFCD08272809
CAS NO::
129938-20-1
Appearance::
White To Off-white Crystalline Solid
Molecular Formula::
C21H24ClNO
Molecular Weight::
341.87400
EINECS NO::
640-411-8
MDL NO::
MFCD08272809
Dapoxe-tine Hydrochloride CAS 129938-20-1

Product Description:

Product Name: Dapoxe-tine hydrochloride CAS NO: 129938-20-1

 

 

Synonyms:

(1S)-N,N-dimethyl-3-naphthalen-1-yloxy-1-phenylpropan-1-amine,hydrochloride;

(S)-N,N-Dimethyl-α-[2-(1-naphthyloxy)ethyl]benzylamine Hydrochloride;

(S)-N,N-Dimethyl-α-[2-(1-naphthyloxy)ethyl]benzylamine Hydrochloride;

 

 

Chemical & Physical Properties:

Appearance: White to off-white crystalline solid

Assay :≥99.00%

Boiling Point: 454.4℃ at 760 mmHg

Melting Point: 175-179℃

Flash Point: 132.6℃

Vapor Pressure: 1.27E-09mmHg at 25℃

Storage Condition: -20℃ Freezer

 

 

Safety Information:

HS Code: 2922199090

Hazard Declaration: H302; H319; H413

Signal Word: Warning

Caution Statements: P305 + P351 + P338

Symbol: GHS07

Hazard Codes: Xn,N

 

 

Dapoxe-tine, marketed as Priligy and Westoxetin, among and other brands, is the first compound developed specially for the treatment of premature ejaculation (PE) in men 18–64 years old. Dapoxe-tine works by inhibiting the serotonin transporter, increasing serotonin's action at the post synaptic cleft, and as a consequence promoting ejaculatory delay. As a member of selective serotonin reuptake inhibitor (SSRI) family, dapoxe-tine was initially created as an antidepressant. However, unlike other SSRIs, dapoxe-tine is absorbed and eliminated rapidly in the body. Its fast acting property makes it suitable for the treatment of PE but not as an antidepressant.

Originally created by Eli Lilly pharmaceutical company, dapoxe-tine was sold to Johnson & Johnson in 2003 and submitted as a New Drug Application to the Food and Drug Administration (FDA) for the treatment of PE in 2004. Dapoxe-tine has been sold in several European and Asian countries, and lately in Mexico. In the US, dapoxe-tine has been stuck in phase III development since 2003. However, it is expected to be marketed soon. In 2012, Menarini acquired the rights to commercialise Priligy in Europe, most of Asia, Africa, Latin America and the Middle East.

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.